glp-1 latest use tripled among non-diabetics, reaching $5.8B in 2022 GLP-1 weight-loss drugs may also

In March 2013, the agency announced it was gathering more data on Januvias link to pancreatitis and possible pancreatic cancer

Official Recommendations from Novo Nordisk Novo Nordisk, Ozempics maker, has specific advice for its use in patients with gallbladder issues or those who had gallbladder surgery

Anamorelin is the first therapeutic drug in this field and holds the potential to improve the mortality rate and quality of life of cancer patients

Variants in FTO , the fat-mass and obesity-associated gene, along with GLP1R (the GLP-1 receptor gene that every GLP-1 compound targets), MC4R (a melanocortin receptor tied to satiety and energy balance), and TCF7L2 (a transcription factor linked to glucose homeostasis) describe the metabolic terrain a clinician is prescribing into

As a Pharm.D graduate and medical writer, I enjoy exploring evidence-based topics that bridge pharmacology and patient education

However, these drugs are associated with a wide array of side effects, and some say alternatives are needed